Breathing Lung-on-a-Chip from One Human Donor Advances Personalized Medicine
Originally written in Genetic Engineering and Bitotechnology News on January 2, 2026
Credit: TefiM / iStock / Getty Images Plus
Air sacs in the lungs called alveoli are crucial for gas exchange and provide an important barrier against inhaled viruses and bacteria that cause respiratory diseases like flu and tuberculosis (TB). However, there remains a gap in developing immunocompetent and experimentally accessible alveolar systems to study human respiratory diseases.
In a new study published in Science Advances titled, “Autologous human iPSC–derived alveolus-on-chip reveals early pathological events of Mycobacterium tuberculosis infection,” researchers from the Francis Crick Institute and AlveoliX have developed what they describe as the first human lung-on-a-chip model using stem cells taken from a single human donor. The chip can simulate breathing motions and lung disease in an individual, holding promise for testing treatments for infections like TB and delivering personalized medicine.
Due to its significance in homeostasis and promise for drug delivery, many in vitro human models have been developed to circumvent the differences in anatomy, immune cell composition, and disease pathogenesis between human and animals. Organ-on-chip technologies have emerged as predictive tissue modeling tools and reliable alternative to animal testing.

Comments
Post a Comment